Residents wait for nucleic acid testing at Balizhuang Subdistrict in Chaoyang District, Beijing, capital of China, June 11, 2022. (Xinhua/Li Xin)
A medical worker takes a swab sample from a resident for nucleic acid testing at Balizhuang Subdistrict in Chaoyang District, Beijing, capital of China, June 11, 2022. (Xinhua/Li Xin)
A medical worker takes a swab sample from a resident for nucleic acid testing at Balizhuang Subdistrict in Chaoyang District, Beijing, capital of China, June 11, 2022. (Xinhua/Ju Huanzong)
A medical worker takes a swab sample from a resident for nucleic acid testing at Balizhuang Subdistrict in Chaoyang District, Beijing, capital of China, June 11, 2022. (Xinhua/Li Xin)
A medical worker takes a swab sample from a resident for nucleic acid testing at Balizhuang Subdistrict in Chaoyang District, Beijing, capital of China, June 11, 2022. (Xinhua/Ju Huanzong)
A resident takes nucleic acid testing at Balizhuang Subdistrict in Chaoyang District, Beijing, capital of China, June 11, 2022. (Xinhua/Ju Huanzong)
Residents register for nucleic acid testing at Balizhuang Subdistrict in Chaoyang District, Beijing, capital of China, June 11, 2022. (Xinhua/Li Xin)
A resident takes nucleic acid testing at Balizhuang Subdistrict in Chaoyang District, Beijing, capital of China, June 11, 2022. (Xinhua/Ju Huanzong)
A medical worker takes a swab sample from a resident for nucleic acid testing at Balizhuang Subdistrict in Chaoyang District, Beijing, capital of China, June 11, 2022. (Xinhua/Ju Huanzong)
